Dynavax Technologies Corp.
(NASDAQ : DVAX)

( )
DVAX After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
MRNAModerna, Inc. -6.72%174.070.0%$1639.17m
NVAXNovavax, Inc. -6.21%92.3378.2%$633.32m
AMGNAmgen, Inc. -1.08%231.301.4%$520.34m
BIIBBiogen, Inc. -1.28%230.811.8%$499.50m
GILDGilead Sciences, Inc. -1.93%69.071.0%$465.79m
BNTXBioNTech SE -4.47%161.660.0%$438.57m
REGNRegeneron Pharmaceuticals, Inc. 1.13%618.112.7%$392.67m
ILMNIllumina, Inc. 0.32%384.363.3%$386.08m
VRTXVertex Pharmaceuticals, Inc. -0.10%230.841.9%$334.35m
SNSSSunesis Pharmaceuticals, Inc. -4.00%2.880.7%$201.32m
EXASEXACT Sciences Corp. -1.67%76.1317.9%$160.64m
ARNAArena Pharmaceuticals, Inc. -0.51%91.5113.7%$138.71m
ALNYAlnylam Pharmaceuticals, Inc. -0.41%138.628.2%$131.51m
INCYIncyte Corp. -0.31%74.782.4%$129.60m
BBIOBridgeBio Pharma, Inc. -0.51%11.700.0%$104.26m

Company Profile

Dynavax Technologies Corp. operates as a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel vaccines and immuno-oncology therapeutics. Its product includes HEPLISAV-B, which prevents infection caused by all known subtypes of hepatitis B virus in adults 18 years of age and older. The company was founded by Lawrence M. Lichtenstein, Dennis A. Carson, and Eyal Raz on August 29, 1996 and is headquartered in Berkeley, CA.